Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907814 · ClinicalTrials.gov registry record · NA
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02907814 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 6 participants.
The verdict
NCT02907814, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.
Interventions
- DEVICE Optical Coherence Tomography (OCT)
- OTHER Eye Exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907814
The ClinicalTrials.gov registry entry for NCT02907814 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Optical Coherence Tomography (OCT) is the first listed.
NCT02907814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02907814 about?
NCT02907814 is a clinical study titled "Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography". Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intrao...
What is the current status of trial NCT02907814?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-09. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02907814?
The interventions under investigation include: Optical Coherence Tomography (OCT) (DEVICE), Eye Exam (OTHER).
Who is sponsoring clinical trial NCT02907814?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.